Individuals participating in biobanks and other large research projects are increasingly asked to provide broad consent for open-ended research use and widespread sharing of their biosamples and data. We assessed willingness to participate in a biobank using different consent and data sharing models, hypothesizing that willingness would be higher under more restrictive scenarios.
INTRODUCTION
Health research increasingly requires very large numbers of participants to be willing to share their biological samples, genomic data, and clinical information with researchers. 1 The proposed Precision Medicine Initiative (PMI) is one prominent example of a very large biobank created to improve understanding of human health and disease. 2; 3 In this type of biobank, participants are asked to share their data not only with the institutions making the request but also with other investigators at diverse sites, often for projects not yet conceived. 4 The National Institutes of Health (NIH) Genomic Data Sharing Policy already requires that NIH-funded researchers proposing to generate genomic data obtain broad consent from participants, that is, consent that permits wide data sharing. 5 Obtaining broad consent has also been proposed by the Department of Health and Human
Services and the White House Office of Science and Technology Policy as the preferred approach.
Their 2015 Notice of Proposed Rulemaking (NPRM) required that informed consent be obtained
for all research using tissue samples and most clinical data, and stated that such consent can be obtained in a one-time, open-ended or 'broad' fashion. 6 Obtaining broad consent from participants in biobanks reduces administrative burdens and may accelerate discovery. 5 However, broad consent and wide data sharing reduces participants' control over how their data is used. 7; 8 Individuals who object to decreased control may be less willing to take part in the research. [9] [10] [11] [12] [13] Decreased willingness to participate in research is of particular concern for populations who are already underrepresented in medical research. Most genomics research to date has used data predominantly from individuals of Northern European ancestry, limiting the insights gained for individuals of other ancestries. [14] [15] [16] [17] [18] Ancestry is only imperfectly correlated with the social constructs of race and ethnicity, but this association does mean that perspectives on research participation within underserved groups can influence inclusion from underrepresented ancestry groups. Some racial and ethnic groups, including African-Americans, have less trust in medical researchers than others, 19; 20 so that the move towards broad consent could undermine muchneeded efforts to increase participation in medical research among underrepresented groups.
Members of the public are key stakeholders in this discussion. 21 A recent systematic literature review 22 reported that, when presented with different consent models and asked to choose among them, individuals often favor greater levels of control and select more specific types of consent over broad consent. [23] [24] [25] These findings could have serious implications for large-scale research efforts. Asking respondents to choose from among several consent or data sharing options is quite different, however, from asking them to enroll in a particular biobank with a defined data sharing policy. In addition, it is unclear whether respondents to these previous surveys truly understood the trade-offs involved, or whether they were simply endorsing the idea of greater choice more generally. As noted in the same review, previous studies have also tended to be small and local, and underrepresent key demographic groups. 22 We therefore conducted a large survey of attitudes towards consent and data sharing in biobank research among diverse participants recruited at multiple healthcare systems participating in the Electronic Medical Records and Genomics (eMERGE) Network. 26 The eMERGE Network is ideal for this type of research, as it has the necessary infrastructure and access to a large diverse population of individuals who are among those most likely to be invited to participate in a biobank. The overarching aim of the present study was to examine patients' attitudes towards participating in biobank research using an experimental study design that randomly assigned participants to different consent and data sharing conditions.
We hypothesized that participants randomly assigned to a hypothetical biobank with broad consent and open data sharing would express less willingness to participate in, and have more negative attitudes towards, the biobank than those assigned to a biobank with tiered consent and controlled data sharing. We also hypothesized that willingness would be lower among participants of lower socioeconomic status and from underserved racial and ethnic groups. In addition, we examined participants' perceived benefits, concerns, and information needs regarding participating in biobank research.
SUBJECTS AND METHODS

Study design and procedures
This was an experimental survey study. Individuals were randomly assigned to one of three conditions and completed self-report questionnaires. Participants were patients who had: (1) sought care for themselves or their minor child at one of 11 eMERGE Network sites 26 between
October 1, 2013 and September 1, 2014; (2) a valid address that could be geocoded; and (3) age and sex available in the electronic health record. To maximize diversity of the sample, and specifically to enrich the observed sample with demographic groups that have been underrepresented in previous studies, we utilized a disproportionate stratified sampling scheme.
Strata were defined by the cross-classification of patient age group (at adult centers: ≤35 years and >35 years; pediatric centers: ≤12 years and >12 years), sex, race (White, Black, Asian, Native
American/Alaska Native, Hawaiian/Pacific Islander, Other), ethnicity (Hispanic/Latino or not), education group (<12 years, 12-15 years, 16+ years), and residence in a rural vs. urban/suburban census block group. To be able to execute this complex study design, values for each stratification variable needed to be known (or estimated) prior to randomization. Many of these items, as well as home address, were readily available in the EHR. Others were incomplete or were inaccurate.
Home addresses were geocoded and linked to unique census block groups. Information from the 2010 census and 2008-2012 American Community Survey were used to impute missing stratification information, using the mode of the participant's census block group value, in order to define the 'approximate' sampling frame. Further details on the sampling frame and the stratified sampling strategy are provided in Table S1 and Table S2 . A thorough exposition of the sampling scheme, including how census data were utilized for the purpose of sampling, are provided in an upcoming journal article. The sampling frame was approximately 2.4 million patients of whom 90,000 were selected.
Participants within each sampling stratum were randomized to receive a survey which included one of three hypothetical biobank scenarios. The scenarios were identical except for the details regarding consent type and data sharing approach. 27 In the first scenario, donated samples and data could be used for all kinds of medical research and data could be shared with approved investigators only ('broad-controlled'). The second and third scenarios contained an alternative consent approach or data sharing policy: in the 'tiered-controlled' scenario, the consent process allowed participants to select the types of research for which their samples and data could be used; and in the 'broad-open' scenario, the data sharing policy allowed de-identified data to be shared through an online database open to the public.
Pre-notification postcards were mailed, after which optical scan surveys were mailed along with a non-contingent pre-incentive $2 bill, to potential participants in April 2015. Non-respondents received a reminder letter in May 2015 and a second survey in July 2015. Participants could complete the survey on paper and return it in a self-addressed stamped envelope or complete an identical survey through a secure, online survey interface on the REDCap database platform.
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Development of the survey instrument
The survey instrument, including the three hypothetical scenarios and the survey questions, was developed by a multidisciplinary expert working group, informed by the findings from a systematic review of the literature. 22 A complete draft of the survey instrument content was tested and refined using cognitive interviews with 40 patients across six sites. A pilot study to test the feasibility of the survey instrument and study procedures was then conducted across all 11 sites. In the pilot study, 166 respondents returned the survey, out of 1500 patients who were sent the survey (response rate 11%). Analysis of pilot data suggested that planned study procedures were robust, and quality indicators including incomplete surveys and straight-lined responses necessitated only minor revisions to the survey. Respondents to the pilot survey were excluded from the main study, and responses to the pilot were not included in the main analysis.
Survey measures
Demographics Standard measures of demographic characteristics were used. 29; 30 Poverty was calculated from income and number of people in household. Rurality was assessed using censuslevel data. Religiosity was assessed using an item adapted from previous research. 31 Self-rated health, an indicator of quality of life, was assessed using the widely-used single item from the SF-12.
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Trust and privacy Concern about privacy was assessed using two items. 33 Trust was assessed with two items.
34; 35
Willingness to participate Willingness to participate in the hypothetical biobank described was assessed using a single item adapted from previous research.
25; 36
Attitudes towards participating
Attitude items were either generated specifically for this study, or adapted from previous research. 24; 25; 37-40 In order to generate these items, the multidisciplinary expert working group defined three relevant sub-domains to be assessed within the overarching domain of 'attitudes towards participating in a biobank': perceived benefits of participating in the described biobank, concerns about participating in the described biobank, and information needs about the governance of the described biobank (e.g. how decisions are made regarding the use of the samples and data). Initial lists of items to assess each of these sub-domains were compiled based on a review of the literature on these topics 22 and on expert input. The lists were culled in an iterative manner, in order to produce a manageable number of prioritized items that would not over-burden participants. The final list comprised five items assessing perceived benefits, six items assessing concerns, and eight items assessing information needs. Likert-style scales were used with 5 responses ranging from 'strongly disagree' to 'strongly agree' for each item. Factor analysis confirmed that benefits, concerns and information needs were distinct factors, with all items from each set loading on that factor with eigenvalues greater than 0.4. In order to describe responses to these items, responses were dichotomized and proportions responding 'agree' or 'strongly agree' with each statement were reported. In addition, composite scale scores were created by calculating the mean of each set of items (possible range from 1 to 5). Mean scores were described for each attitudinal scale. In addition, for the purposes of the regression analysis (see below), participant's scale scores were categorized: scale scores ranging from 1.0 to 2.50
were categorized as 'low'; scale scores ranging from 2.51 to 3.50 were categorized as 'intermediate'; and scale scores ranging from 3.51 to 5.0 were categorized as 'high'. The three survey instruments are available online (see Web resources).
Data analysis
Response rates were calculated according to American Association for Public Opinion Research (AAPOR) criteria. 41 To determine if randomization was maintained within the subset of respondents, sample counts and percentages were calculated for socio-demographic variables.
These summaries were computed within consent and data sharing models across all sites and compared using the Pearson's Chi-Square test. For all other analyses, each participant was assigned a post-stratified, sampling weight (i.e., the inverse of the probability of being sampled and answering the survey) to account for the stratified sampling design. Because understudied populations were intentionally oversampled, sampling weights varied dramatically within and across sites, and so we conducted site-specific weight trimming and redistribution combining two commonly used approaches: weights were trimmed at (1) the 90 th percentile of weights, or (2) the median+6*IQR, whichever was higher. 42; 43 Recognizing that all trimming approaches are ad hoc, we conducted sensitivity analyses for the primary analysis using a number of approaches to trimming. Results from sensitivity analyses can be found in Table S3 .
The impact of consent and data sharing models on willingness to participate in biobank research was estimated with a (survey weighted) three-level multinomial logistic regression (probably not / definitely not; not sure; yes probably / yes definitely) with linearized covariance estimates of uncertainty. For ease of exposition, all combined estimates (across multiply imputated datasets within a site and then across sites) were transformed and are reported as probabilities (or percentages). Comparisons among data sharing and consent models were performed via a Waldtest from an ordinal logistic regression, proportional odds model. Similar methods were applied to estimate the impact of consent and data sharing models on each of the three attitudinal constructs (perceived benefits, concerns, and information needs).
To identify demographic and other characteristics associated with willingness to participate in biobank research, willingness was dichotomized (yes = agree / strongly agree; no = not sure / disagree / strongly disagree), and was regressed on covariates using unadjusted (marginal) and adjusted logistic regression analyses. Adjusted models were fitted hierarchically using sociodemographic variables first; adding trust and privacy items second; and adding the attitudinal constructs third. Unadjusted estimates were summarized with percentages, and adjusted estimates of covariates associations with willingness to participate were summarized with oddsratios and associated 95% confidence intervals. Sub-domain analyses were performed to quantify the extent to which the relationship between survey type and willingness differed across sociodemographic variables. There was little to no evidence to suggest that such interactions existed (not shown). Responses to the individual attitudinal items were described, and 95% confidence intervals were computed.
Multiple imputation was conducted within each site to account for item non-response, which ranged from less than 1% to 5% for all key variables except income (8%). We used sociodemographic variables, biobank participation willingness, attitudinal constructs, and deciles of post-stratified weights to impute all missing data. 44 Ten complete imputation data sets were created for each site. Survey weighted regression analyses were performed on each complete data set and combined using the standard 'Rubin's rules'. 45 For every analysis, site-specific estimates were then combined to summarize characteristics of the entire eMERGE Network using multivariate random-effect, meta-analytic methods. 46 All analyses were performed using R Version
(R Project for Statistical Computing) and Stata Version 14 (StataCorp).
RESULTS
Participant characteristics
Socio-demographics Of 90,000 surveys mailed, 7,672 individuals were ineligible due to invalid address, death, or incapacity, and 681 refused to participate. Of the 82,328 eligible individuals, exactly 13,000 responded (AAPOR reponse rate 15.8%). Among responders, 11,712 completed the paper (91.9%) and 1,288 the online (9.9%) survey. Sixty-three percent of participants were female; 51% self-identified as White; 18% as Hispanic; 42% had less than a Bachelors degree;
and 44% had an annual household income of $60,000 or less ( Table 1 ). There were no sociodemographic differences among participants receiving each of the three scenarios, indicating randomization was successful.
Trust and privacy Ninety percent of participants agreed health information privacy was important to them; 64% agreed that they worried about the privacy of their health information. Two thirds agreed that they trusted their healthcare system (64%) and medical researchers (61%). There were no differences in participants' trust and privacy among the three biobank scenario groups ( Table 2) .
Willingness compared between scenario groups
Overall, 66% (95% CI: 63-69%) of participants stated that they would be willing to participate in the biobank described to them ( 
Attitudes compared between scenario groups
Mean attitude scores (where 1 indicates low, 5 indicates high) were 3.85 for perceived benefits, 3.11 for concerns, and 3.95 for information needs overall. Mean scores did not differ between experimental conditions (see Table 3 ).
Associations between willingness and participant characteristics
Because patterns of associations between socio-demographic variables and willingness were the same within each of the consent and data sharing conditions separately, and because willingness did not differ at the .001 level between groups, all subsequent analyses were conducted on the sample as a whole.
The following participant characteristics were independently associated with willingness to participate before attitudes were entered into the model: race (as self-reported by the respondent in the survey), education, religiosity, and trust and privacy concerns ( Table 4) . Black or African
American participants expressed the lowest levels (56%) and White participants the highest levels When attitudes toward the biobank were entered into the model, each of the three composite scale variables was independently associated with willingness: participants were more willing to participate if they perceived more benefits, fewer concerns, and had fewer information needs ( Table 4 ). In this model, education and religiosity remained associated with willingness, but race, trust and privacy concerns did not.
Benefits, concerns, and information needs
The most endorsed benefit in the sample overall was, "I would feel that I was helping future generations" (84%, 81-87%), the least endorsed benefit was "I would feel that taking part could help me personally" (44%, 40-47%). The most endorsed concern was, "I would worry about my privacy" (51%, 47-55%); the least endorsed concern was, "I would worry that someone might make money using my health information" (36%, 33-39%). The most endorsed information need about biobank governance was, "I would want to know what would happen if a researcher misused the health information in the biobank" (86%, 84-87%); the least endorsed information need about biobank governance was, "I would want to know if my health information might be used by drug companies that make money" (59%, 56-61%) ( Table 5) .
DISCUSSION
This is the largest survey of patients' attitudes towards participating in biobank research to date. In this study, we found no evidence to support the hypothesis that asking potential biobank participants to provide broad consent or permit open data sharing would lead to less willingness to participate than asking them to provide tiered consent or permit controlled data sharing. Models of consent and data sharing had limited relevance to participants' decision-making when they were asked to make a decision about whether to participate in the single biobank scenario presented to them. These findings are consistent with previous research reporting that overall acceptance of broad consent is similar to that of specific or tiered consent, although a number of factors may influence this preference.
23-25
Our use of an experimental design and randomization means participants were presented with a decision that was closer to the real world than previous studies that have given participants choices and asked which consent model they preferred. Individuals may have pre-existing global views regarding participating in biobank research (i.e. they are generally open to, or generally against, participating), which are not swayed by the consent and data sharing models presented to them. It is also possible that many participants did not read the scenario carefully, and were therefore responding to the general idea of participating in a biobank rather than the specific scenario presented to them. While this should certainly be considered a possible limitation of our findings, it is also possible that this lack of attention to detail simulates, in some ways, the attention potential biobank participants give to analogous details in a real biobank consent document.
Our findings support the hypothesis that socio-demographic characteristics are associated with willingness to participate in biobank research. Consistent with previous research, 47; 48 willingness to participate in a biobank was significantly lower among participants who self-identified as Black or African American and those with lower levels of educational attainment. Although religiosity is difficult to assess, participants who self-identified as more religious on this simple measure were less willing to participate. Little research has previously explored associations between religiosity and attitudes regarding biobank participation, 49 but other investigations have shown religiosity is associated with negative perceptions of the value of science and technology. [50] [51] [52] [53] Our findings support previous indications that certain socio-demographic groups will require greater efforts to ensure participation in large research initiatives going forward. Our results have implications particularly for biobanks that plan to rely on recruitment of volunteers, such as the PMI, rather than selection to represent the population. Unless there is an attempt to over-enroll underrepresented groups, as we did in our survey study, large studies like the PMI may end up with cohort samples that do not adequately represent the US population.
We also found that, consistent with previous research, 23; 37 willingness to participate in biobank research was lower among respondents with more concerns about privacy and lower levels of trust. When designing recruitment strategies, researchers and institutions may be able to address these trust and privacy concerns at a local level by building relationships with their communities, and at a national level by implementing new policies and public education and engagement strategies. We also found, however, that these associations between privacy, trust and willingness were no longer statistically significant after attitudes towards biobank research (benefits, concerns, information needs about governance) were added in to the model. This further suggests that outreach and engagement conveying the benefits of biobank research, and addressing concerns and information needs, may be important and achievable strategies to including more diverse populations in these research efforts.
We found that participants were more concerned about some risks than others, and wanted to know more about some aspects of governance than others. These findings may be of particular value to researchers, institutions and organizations involved in developing public education and information materials about biobanks, as they shed valuable light on what potential participants want to know about research.
Limitations include a low response rate. Although this was not unexpected given our recruitment method and efforts to oversample populations typically less willing to participate in research, we cannot know how much opinions of nonresponders would differ. However, it seems unlikely that nonresponders would be more willing to enroll in biobanks. Our study also relied on participants' self-reported intentions and hypothetical scenarios, rather than actual behavior. It is also possible that participants did not read all of the hypothetical scenario, and so may not have appreciated the detail regarding the consent and data sharing model. They did, however, have opinions about other aspects of the proposal which suggests substantial engagement with the survey. The limitations need to be weighed against the study's strengths, which include broad geographical and diverse institutional coverage, a rigorous sampling strategy, and experimental design.
In conclusion, the results from this study suggest that biobanks using broad consent may not be less successful in recruiting participants than if they use more specific consent approaches.
Open data sharing may be almost as acceptable to participants as controlled data sharing. Some socio-demographic groups differ in their willingness to participate in biobank research. Individuals discriminate between different positive and negative aspects of biobank participation, and feel more strongly about knowing about some aspects of biobank governance than others. Targeted interventions designed to recruit underrepresented groups, to make biobank information easier to understand, and to address individuals' specific attitudes about participating in a biobank may help increase acceptance of broad consent and open data sharing in biobank research. These findings may be of use to biobank investigators concerned with how biobanks are governed and to policy makers working to revise regulations on the protection of human research subjects.
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